|
|
Volumn 7, Issue 2, 2007, Pages 127-
|
|
Editorial
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADRENALIN;
ADRENERGIC RECEPTOR;
ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT;
ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT;
ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT;
ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
ALPHA ADRENERGIC RECEPTOR;
BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT;
BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT;
BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT;
BETA ADRENERGIC RECEPTOR;
ANALGESIA;
ANESTHESIA;
ATTENTION DEFICIT DISORDER;
BINDING AFFINITY;
BINDING SITE;
BIOASSAY;
BRONCHODILATATION;
DRUG EFFICACY;
DRUG INDICATION;
DRUG RECEPTOR BINDING;
DRUG SAFETY;
DRUG STRUCTURE;
DRUG TARGETING;
DRUG USE;
EDITORIAL;
GENE TARGETING;
GENETIC VARIABILITY;
HUMAN;
HYPERTENSION;
MOLECULAR BIOLOGY;
NOSE CONGESTION;
OTITIS;
OVERACTIVE BLADDER;
PROSTATE HYPERTROPHY;
PROTEIN INTERACTION;
PROTEIN STRUCTURE;
RECEPTOR BINDING;
SECOND MESSENGER;
STRESS INCONTINENCE;
STRUCTURE ANALYSIS;
THREE DIMENSIONAL IMAGING;
|
|
EID: 33846065229
PISSN: 15680266
EISSN: None
Source Type: Journal
DOI: 10.2174/156802607779318226 Document Type: Editorial |
|
Times cited : (1)
|
|
References (0)
|
